Mavengity Expands into B2B Research
Owner Marko Pargo Ivanov is now writing the B2B Research desk directly, turning Forrester and Gartner category reports into plain-English breakdowns for buyers.
Read the Article8th Circuit ruling
6 storiesS-1 public filing
1 storySenate committee report Nov 20
1 storyCourt resolves the dismissal and stay motions Nov 20
1 storyComment deadline on the RFI Nov 23
2 storiesTesla annual shareholder meeting Dec 3
A three-judge panel found the Federal Motor Carrier Safety Administration imposed an expiration-matching requirement for commercial licenses that the regulation did not contain, and ordered the $73.5 million released.
Intellia's integrated data show an 89% attack-rate reduction and 100% of patients off long-term prophylaxis up to four years. The FDA's decision on lonvo-z is due March 10.
The FDA ordered class-wide label changes after a review of 126 trials found a small increase in NAION, a rare condition that can cause sudden, permanent vision loss.
A 43-state settlement requires the rent-to-own lender to pay $183.5 million, stop marking up cash prices, and keep its agreements off consumer credit reports for five years.
Bloomberg reported the talks are moving faster, with an announcement possible in December, while the exchange ratio and Tesla's China business remain unresolved.
The fast-track program has awarded 22 vouchers and approved about a dozen drugs, but no new vouchers since May, a dormant oversight council, and nine reviews now back with career scientists.
Arrowhead said its severe hypertriglyceridemia application is filed and on a six-month FDA review track, setting up a 2027 launch against a competitor already selling into the same patients.
The suit in San Francisco Superior Court asks a judge to bar Anthropic, Google, Meta, OpenAI, and SpaceX from developing or deploying new models, citing catastrophic risks.
A final rule effective Dec. 14 requires citizenship or eligible immigration status verification for every assisted household member, regardless of age, and limits prorated aid.
Non-English intent signal is still under twenty percent of total volume industrywide, which means most platforms are seeing a fraction of the buying activity happening outside English language markets.
One vendor is explicitly competing on restraint, arguing that a plausible AI generated article that is subtly wrong is worse for a knowledge base than no article at all.
Forrester's own buyer guidance undercuts the AI pitch: providers are getting measurably more efficient, and there is little evidence yet that any of that efficiency is reaching customer pricing.
Forrester's guidance to buyers is blunt: having a data centre in the EU answers one sovereignty question out of four, and most vendor pitches stop at the first.
Forrester frames 2026's binding constraint as a workforce that cannot be trained fast enough, which makes this a services category built around people more than platforms.
Forrester's Q3 2026 Wave scores ten providers against twenty nine criteria, cutting the field's criteria count for the first time, while a vendor that owns its content finishes last equal.
Two of the category's most prominent independent players are now owned by the card networks they were supposed to route around.
Forrester's provider count nearly doubled in three years, and every other technology category in this series points at the same root cause: the software works and the organisation does not change.
Every reference customer for one vendor said they would buy again, which in PLM can mean genuine excellence or a customer base that has nowhere else to go once the evidence chain is built.
Owner Marko Pargo Ivanov is now writing the B2B Research desk directly, turning Forrester and Gartner category reports into plain-English breakdowns for buyers.
Read the ArticleWith James now writing full time for our Healthcare & Medical desk, Mavengity has formally expanded into dedicated medical authorship.
Read the Article